Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System

Rhea-AI Summary

Izotropic Corporation (OTCQB: IZOZF) announced placement in an editorial by NetworkNewsWire on October 24, 2025 highlighting AI-driven imaging firms targeting the breast cancer market.

The company is noted for its IzoView Breast CT Imaging System, a purpose-built 3D solution aimed at improving detection accuracy, especially in women with dense breast tissue. The release cites WHO and ACS data on global and U.S. breast cancer incidence to frame market demand.

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.

To view the full publication, “Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market,” please visit: https://nnw.fm/qBAbh

Artificial intelligence (AI) continues to transform healthcare innovation, with medical imaging emerging as one of its most promising frontiers. In breast cancer detection, where early identification often determines patient outcomes, AI-powered imaging technologies are pushing beyond the technical constraints of traditional mammography, tomosynthesis, and MRI. Globally, breast cancer remains the most frequently diagnosed cancer among women. The World Health Organization (WHO) reported that more than 2.3 million women were diagnosed, with approximately 670,000 losing their lives to the disease in 2022. In the United States, the American Cancer Society (ACS) estimates that 316,950 new invasive breast cancer cases will be identified this year alone.

This urgent demand for faster, more accurate diagnostic tools is driving a surge of innovation across the imaging sector. Within this fast-evolving field, Izotropic Corporation is distinguishing itself with the IzoView Breast CT Imaging System, a purpose-built 3D imaging solution engineered to enhance cancer detection accuracy, particularly in women with dense breast tissue.

About Izotropic Corporation

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) is a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses and treatment of breast cancers

More information about Izotropic can be found on its website at IzoCorp.com 

NOTE TO INVESTORS: The latest news and updates relating to IZOZF are available in the company’s newsroom at https://ibn.fm/IZOZF

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: https://www.NetworkNewsWire.com/Disclaimer

NetworkNewsWire
New York, NY
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is powered by IBN

FAQ

What did Izotropic (OTCQB: IZOZF) announce on October 24, 2025?

Izotropic announced placement in a NetworkNewsWire editorial highlighting AI-driven imaging firms and referenced its IzoView Breast CT Imaging System.

What is the IzoView Breast CT Imaging System mentioned in the October 24, 2025 release?

The IzoView system is described as a purpose-built 3D breast CT imaging solution designed to enhance cancer detection accuracy, particularly in dense breast tissue.

How does the October 24, 2025 announcement frame market need for Izotropic (IZOZF)?

The announcement cites WHO and American Cancer Society incidence figures to underline demand for faster, more accurate breast cancer diagnostic tools.

Where was Izotropic featured on October 24, 2025 and how can investors view it?

Izotropic was placed in a NetworkNewsWire editorial; the release provides a link to the published article for investor viewing.

Does the October 24, 2025 release claim regulatory approvals for IzoView?

No regulatory approvals or clearance claims are made in the October 24, 2025 announcement.

Will the October 24, 2025 placement in NetworkNewsWire directly change Izotropic's financial guidance?

The October 24, 2025 announcement does not include any financial guidance or quantified revenue impact.